Advertise here
Advertise here
Headlines

Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis

TOPLINE: Higher doses of nonsteroidal anti-inflammatory drugs (NSAIDs) increase the risk for cardiovascular diseases (CVDs) such as ischemic heart disease, stroke, and congestive heart failure in patients with ankylosing spondylitis (AS) compared with lower doses. METHODOLOGY: NSAIDs can suppress inflammation and relieve pain in patients with AS, but long-term treatment with NSAIDs poses concerns regarding…

Read More

Lisata, Eisai x Biogen, and the Met Gala (!)

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Congratulations on almost making it to the end of the week! For that, I have a little treat for you at the bottom of the newsletter. But first, the biotech news of…

Read More

Pandemic talks extended as deadline passes

Credit: Unsplash/CC0 Public Domain Countries trying to strike a landmark global agreement on handling future pandemics decided to keep negotiating for another fortnight after their deadline passed on Friday. Scarred by the devastation caused by COVID-19—which killed millions, shredded economies and crippled health systems—the World Health Organization’s 194 member states have spent two years trying…

Read More

Immunosuppression Risk Factor for Poor cSCC Outcomes

PHOENIX — Immunosuppression is an independent risk factor for poorer outcomes in patients with cutaneous squamous cell carcinoma (cSCC), according to new research that was presented at the American College of Mohs Surgery (ACMS) 2024 Annual Meeting. Even though immunosuppression is strongly associated with an increased risk for cSCC, studies to date have generally not…

Read More

Cytokinetics pitches its heart drug

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox. I love the Cytokinetics story. There’s so much at stake with aficamten, not to mention all the ups and downs from previous drug-development efforts and now the speculation about…

Read More

Brazilian Society of Cardiology Updates Three Guidelines

The Brazilian Society of Cardiology (SBC) has just updated its guidelines on hypertension and ambulatory blood pressure monitoring (ABPM), ergometry, and hypertrophic cardiomyopathy (HCM). The new versions of the recommendations were presented at the SBC’s 1st Meeting of Cardiology Departments in São Paulo. The event was attended by 12 departments of the society and the…

Read More

Jennifer Adair on making gene therapy available globally

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world. These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and…

Read More

Prevention of Diabetes Complications Lags in Latin America

An alarming lack of compliance with assessments to prevent ophthalmologic and neuropathic complications associated with diabetes has been detected in nine countries in Latin America and the Caribbean. Only three territories (Chile, Brazil, and the British Virgin Islands) had more than 50% of patients with diabetes who had received an eye examination in the previous…

Read More

What to know about H5N1 bird flu

What happens when a common virus jumps from birds to cows? And should we be concerned? This week on “The Readout LOUD,” STAT senior infectious diseases reporter Helen Branswell walks us through ongoing H5N1 outbreak in the U.S. and issues with monitoring the spread. It’s also Pulitzer week at “The Readout LOUD”! In a bit…

Read More

EMA Embarks on Psychedelic Trip

May 7, 2024, LinkedIn Live — It’s the Age of Aquarius. Representatives from the European Medicines Agency (EMA) held a virtual meeting for researchers, journalists, and other interested parties, where it announced plans to revisit the therapeutic potential of psychedelic compounds for mental health conditions such as treatment-resistant depression, addictive disorders, posttraumatic stress disorder, and…

Read More

Study traces an infectious language epidemic

Our research empirically links social media conversations to national health outcomes related to COVID-19. We introduce Role-Based Incremental Coaching (RBIC), a Large Language Model (LLM) prompting framework. (A) Collecting Reddit datasets focused on communities known for opposing COVID-19 health practices. (B) Guided by Fuzzy-Trace Theory, we introduce a novel LLM framework called Role-Based Incremental Coaching…

Read More

Daily-life input and developmental nourishment

What do infants see? What do they look at? The answers to these questions are very different for the youngest babies than they are for older infants, children and adults. Characterized by a few high-contrast edges in simple patterns, these early scenes also contain the very materials needed to build a strong foundation for human vision.  That…

Read More

US County-Level Study Shows Benefits of PSA Screening

TOPLINE: US counties with higher rates of prostate-specific antigen (PSA) screening have lower rates of advanced/metastatic prostate cancer and prostate cancer mortality in later years, a county-level population-based study suggests. METHODOLOGY: Clinicians continue to debate the benefits and harms of PSA screening. To help clarify the value of PSA screening, researchers assessed the association between…

Read More

What nurses really want: sufficient staffing for patient care

Pizza. Coloring books. Goody bags. They could be activities at a 5-year-old’s birthday party. But they’re not: These are many employers’ attempts to lift the morale of nurses on the frontlines of chronically understaffed organizations. What nurses really want are better working conditions so they can deliver the best care possible to their patients. As…

Read More

Stress hormone during pregnancy linked to IQ in children

Credit: CC0 Public Domain Higher levels of the stress hormone cortisol during the third trimester of pregnancy may impede intelligence quotient (IQ) scores in boys aged 7 years old, according to research presented at the 26th European Congress of Endocrinology, held 11–14 May, in Stockholm. Surprisingly, cortisol levels in the blood are not associated with…

Read More

Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapy

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, “Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy.” In this new editorial, researcher Ioannis A. Voutsadakis from Sault Area Hospital and Northern Ontario School of Medicine discusses tumor mutation burden (TMB)-;a novel clinical biomarker for prediction of checkpoint inhibitor immunotherapy…

Read More

Serum Metabolome Identifies Cancer in Rheumatic Disease

TOPLINE: A diagnostic model based on the concentrations of four metabolites and one lipid ratio can reliably predict cancer in patients with rheumatic and musculoskeletal diseases (RMDs) or paraneoplasia, providing high sensitivity and specificity. METHODOLOGY: The metabolome profile can differentiate between nonspecific inflammatory symptoms such as those associated with paraneoplastic conditions or RMDs, which can…

Read More

FDA Panel Recommends Makena Be Withdrawn From the Market

Following a 3 day meeting, the Food and Drug Administration’s (FDA) Obstetrics, Reproductive, and Urologic Drugs Advisory Committee voted to recommend that the FDA pursue withdrawal of Makena (hydroxyprogesterone caproate injection) from the US market. Makena is indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of…

Read More

Late-stage study finds menopause drug fezolinetant safely reduces hot flushes for almost six months

Credit: Pixabay/CC0 Public Domain Fezolinetant reduces the frequency and severity of hot flushes during menopause for 24 weeks, without serious side effects, according to research presented at the 26th European Congress of Endocrinology, held 11–14 May, in Stockholm. These findings provide further evidence of the benefits of using this non-hormonal preventative drug in women experiencing…

Read More

New biomedical engineering innovation shows potential to transform trauma care and surgical practices

A breakthrough study, published in Science Translational Medicine, features a biomedical engineering innovation with the potential to transform trauma care and surgical practices. Chapman University’s Fowler School of Engineering Founding Dean and Professor, Andrew Lyon, is a member of this multidisciplinary, multi-university scientific research team developing platelet-like particles that integrate into the body’s clotting pathways…

Read More

CDC Releases Updated Guidance on Prescribing Opioid Pain Medication

The Centers for Disease and Prevention (CDC) has released updated recommendations for clinicians who are prescribing opioids for adult outpatients with acute (duration <1 month), subacute (duration of 1 to 3 months), and chronic (duration of >3 months) pain, excluding pain management related to sickle cell disease, cancer-related pain treatment, palliative care, and end-of-life care….

Read More

Sanofi, Novavax, Maze x Shionogi news

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi all. Today we’re talking about improving the global reach of gene therapies, and about why offering access to ancestral populations could be so powerful. We see in a KFF survey that a majority…

Read More

What to Consider When Prescribing Lecanemab

Clinicians interested in treating patients with symptoms of mild cognitive impairment or mild dementia should carefully analyze the potential benefits and harms of monoclonal amyloid beta therapy, including likelihood of side effects and overall burden on the patient, according to researchers at the 2024 annual meeting of the American Geriatrics Society.  Lecanemab (Leqembi) may help…

Read More

ŌURA Unveils 2 New Features for Heart Health

ŌURA, a wearable device company, announced Friday that it has two new heart health features that will become available in late May. One feature is for understanding users’ cardiovascular age and one is for estimating their cardio capacity. ŌURA, which was founded in Finland, offers a wearable ring called the Oura Ring that tracks users’…

Read More

FDA Panel Votes on Tenapanor for Hyperphosphatemia in CKD

The Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee voted in favor (9 to 4) of the use of tenapanor (Xphozah®) as monotherapy for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis, as well as its use in combination with phosphate binders (10 to 2,…

Read More
Advertise here
error: Content is protected !!